Onyx Pharmaceuticals to Present at the Credit Suisse 18th Annual Healthcare Conference
November 04 2009 - 3:00PM
PR Newswire (US)
EMERYVILLE, Calif., Nov. 4 /PRNewswire-FirstCall/ -- Onyx
Pharmaceuticals, Inc. (NASDAQ:ONXX) today announced that it will
present at the Credit Suisse 18th Annual Healthcare Conference on
Wednesday, November 11, at 9:30 a.m. Mountain Time (8:30 a.m.
Pacific Time). Interested parties may access a live webcast of the
presentation on our website at:
http://www.onyx-pharm.com/view.cfm/32/Event-Calendar It is
recommended that listeners log on 15 minutes early in order to
register and download any necessary software. For those unable to
participate during the live webcast, a recorded replay of the
presentation will be available one hour following the conclusion of
the presentation through December 11, 2009. Onyx Pharmaceuticals,
Inc. is a biopharmaceutical company committed to improving the
lives of people with cancer. The company, in collaboration with
Bayer HealthCare Pharmaceuticals, Inc., is developing and marketing
Nexavar®, a small molecule drug. Nexavar is currently approved for
the treatment of liver cancer and advanced kidney cancer.
Additionally, Nexavar is being investigated in several ongoing
trials in a variety of tumor types. For more information about
Onyx, visit the company's website at http://www.onyx-pharm.com/.
Nexavar® (sorafenib) tablets is a registered trademark of Bayer
HealthCare Pharmaceuticals. DATASOURCE: Onyx Pharmaceuticals, Inc.
CONTACT: Alex Santos of Onyx Pharmaceuticals, Inc., +1-510-597-6504
Web Site: http://www.onyx-pharm.com/
Copyright